在一般医疗环境中进行的简短药物干预:对大麻使用结果的系统审查和元分析
Lauren M Berny1,2, Lindsey M Nichols3,4, Maria L Schweer-Collins5,6,7
1Department of Counseling Psychology and Human Services, University of Oregon, Eugene, OR, 97403, USA. lberny@uoregon.edu.
概括
短期药物干预 (BDI) 在一般医疗环境中没有显著的短期或长期影响减少大麻使用或严重性. 然而,在急诊室提供的BDI可能会在长期内适度地减少大麻的消费.
科学领域:
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
- 行为科学 行为科学
背景情况:
- 短期干预 (BIs) 对酒精使用是有效的,但对于非法药物更不有效.
- 大麻使用对健康有重大影响,需要有效的干预措施.
- 关于大麻在一般医疗环境中的短期药物干预 (BDI) 的研究有限.
研究的目的:
- 评估BDI在减少大麻消费和严重性的有效性.
- 评估BDI在不同后续期间的短期和长期结果.
- 根据干预特征,探索BDI效应的异质性.
主要方法:
- 17个随机对照试验 (RCT) 的元分析.
- 混合效应元回归模型用于分析干预特征 (增强疗程,设置,目标,人群).
- 对主要影响和适度的敏感性分析.
主要成果:
- 大麻使用,消费水平或严重程度没有显著的短期减少.
- 大麻使用或消费水平没有显著的长期减少.
- 敏感性测试表明,当BDI在急诊室提供时,大麻消费的长期减少很小,但显著.
结论:
- 总的来说,在一般医疗环境中,BDI在减少大麻使用方面缺乏有效性.
- 当在急救部门交付BDI时,BDI可能更有效,这需要进一步调查.
- 进一步的研究对于提高BDI的有效性和探索大麻使用的替代干预措施至关重要.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
180
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
371
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
371
Clinical Trials
8.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.6K
Drug Control Governance: Regulatory Bodies and Their Impact
255
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
255
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
2.4K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.4K


